Poddar Sakshi Mahesh, Chakraborty Joyeeta, Gayathri Pananghat, Srinivasan Ramanujam
School of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar, India.
Homi Bhabha National Institutes (HBNI), Training School Complex, Mumbai, India.
Cytoskeleton (Hoboken). 2025 Jul;82(7):415-431. doi: 10.1002/cm.21924. Epub 2024 Sep 4.
FtsZ forms a ring-like assembly at the site of division in bacteria. It is the first protein involved in the formation of the divisome complex to split the cell into two halves, indicating its importance in bacterial cell division. FtsZ is an attractive target for developing new anti-microbial drugs to overcome the challenges of antibiotic resistance. The most potent inhibitor against FtsZ is PC190723, which is effective against all strains and species of Staphylococcus, including the methicillin- and multi-drug-resistant Staphylococcus aureus and strains of Bacillus. However, FtsZs from bacteria such as E. coli, Streptococcus, and Enterococcus were shown to be resistant to this inhibitor. In this study, we provide further evidence that the three pairwise bridging interactions, between residues S227 and G191, R307 and E198 and D299 and R202, between S7, S9, S10 β-strands and the H7 helix occlude the inhibitor from binding to E. coli FtsZ. We generated single, double and triple mutations to disrupt those bridges and tested the effectiveness of PC190723 directly on Z-ring assembly in vivo. Our results show that the disruption of S227-G191 and R307-E198 bridges render EcFtsZ highly sensitive to PC190723 for Z-ring assembly. Ectopic expression of the double mutants, FtsZ S227I R307V results in hypersensitivity of the susceptible E. coli imp4213 strain to PC190723. Our studies could further predict the effectiveness of PC190723 or its derivatives towards FtsZs of other bacterial genera.
FtsZ在细菌分裂位点形成环状组装结构。它是参与分裂体复合物形成以将细胞一分为二的首个蛋白质,这表明其在细菌细胞分裂中具有重要性。FtsZ是开发新型抗菌药物以应对抗生素耐药性挑战的一个有吸引力的靶点。针对FtsZ最有效的抑制剂是PC190723,它对葡萄球菌的所有菌株和种类均有效,包括耐甲氧西林和多重耐药的金黄色葡萄球菌以及芽孢杆菌菌株。然而,已表明来自大肠杆菌、链球菌和肠球菌等细菌的FtsZ对这种抑制剂具有抗性。在本研究中,我们提供了进一步的证据,即S7、S9、S10β链与H7螺旋之间的S227与G191、R307与E198以及D299与R202残基之间的三对两两桥接相互作用会阻止抑制剂与大肠杆菌FtsZ结合。我们产生了单突变、双突变和三突变以破坏这些桥接,并直接在体内测试了PC190723对Z环组装的有效性。我们的结果表明,破坏S227 - G191和R307 - E198桥接会使EcFtsZ对PC190723介导的Z环组装高度敏感。双突变体FtsZ S227I R307V的异位表达导致敏感的大肠杆菌imp4213菌株对PC190723超敏。我们的研究可以进一步预测PC190723或其衍生物对其他细菌属的FtsZ的有效性。